Faculté de Médecine, Université Paris Descartes, Paris, France.
PLoS One. 2012;7(4):e34764. doi: 10.1371/journal.pone.0034764. Epub 2012 Apr 10.
The sodium-hydrogen exchanger regulatory factor 1 (NHERF1) binds to the main renal phosphate transporter NPT2a and to the parathyroid hormone (PTH) receptor. We have recently identified mutations in NHERF1 that decrease renal phosphate reabsorption by increasing PTH-induced cAMP production in the renal proximal tubule.
We compared relevant parameters of phosphate homeostasis in a patient with a previously undescribed mutation in NHERF1 and in control subjects. We expressed the mutant NHERF1 protein in Xenopus Oocytes and in cultured cells to study its effects on phosphate transport and PTH-induced cAMP production.
We identified in a patient with inappropriate renal phosphate reabsorption a previously unidentified mutation (E68A) located in the PDZ1 domain of NHERF1.We report the consequences of this mutation on NHERF1 function. E68A mutation did not modify cAMP production in the patient. PTH-induced cAMP synthesis and PKC activity were not altered by E68A mutation in renal cells in culture. In contrast to wild-type NHERF1, expression of the E68A mutant in Xenopus oocytes and in human cells failed to increase phosphate transport. Pull down experiments showed that E68A mutant did not interact with NPT2a, which robustly interacted with wild type NHERF1 and previously identified mutants. Biotinylation studies revealed that E68A mutant was unable to increase cell surface expression of NPT2a.
Our results indicate that the PDZ1 domain is critical for NHERF1-NPT2a interaction in humans and for the control of NPT2a expression at the plasma membrane. Thus we have identified a new mechanism of renal phosphate loss and shown that different mutations in NHERF1 can alter renal phosphate reabsorption via distinct mechanisms.
钠氢交换调节因子 1(NHERF1)与主要的肾磷酸盐转运体 NPT2a 和甲状旁腺激素(PTH)受体结合。我们最近发现 NHERF1 的突变会通过增加肾近端小管中 PTH 诱导的 cAMP 产生来减少肾磷酸盐重吸收。
我们比较了一位患有先前未描述的 NHERF1 突变的患者和对照组中磷酸盐稳态的相关参数。我们在非洲爪蟾卵母细胞和培养细胞中表达了突变的 NHERF1 蛋白,以研究其对磷酸盐转运和 PTH 诱导的 cAMP 产生的影响。
我们在一位不适当的肾磷酸盐重吸收患者中发现了一个以前未识别的突变(E68A),位于 NHERF1 的 PDZ1 结构域。我们报告了该突变对 NHERF1 功能的影响。E68A 突变不会改变患者的 cAMP 产生。在培养的肾细胞中,E68A 突变并未改变 PTH 诱导的 cAMP 合成和 PKC 活性。与野生型 NHERF1 相反,E68A 突变体在非洲爪蟾卵母细胞和人类细胞中的表达未能增加磷酸盐转运。下拉实验表明,E68A 突变体与 NPT2a 没有相互作用,而野生型 NHERF1 和先前鉴定的突变体则与 NPT2a 有很强的相互作用。生物素化研究表明,E68A 突变体不能增加 NPT2a 的细胞表面表达。
我们的结果表明,PDZ1 结构域对于人类 NHERF1-NPT2a 相互作用以及 NPT2a 在质膜上的表达调控至关重要。因此,我们已经确定了一种新的肾磷酸盐丢失机制,并表明 NHERF1 中的不同突变可以通过不同的机制改变肾磷酸盐重吸收。